rs145766807

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_014008.5(CCDC22):​c.1078G>A​(p.Val360Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000463 in 1,209,653 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 18 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.000089 ( 0 hom., 2 hem., cov: 24)
Exomes 𝑓: 0.000042 ( 0 hom. 16 hem. )

Consequence

CCDC22
NM_014008.5 missense

Scores

16

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.0610

Publications

2 publications found
Variant links:
Genes affected
CCDC22 (HGNC:28909): (coiled-coil domain containing 22) This gene encodes a protein containing a coiled-coil domain. The encoded protein functions in the regulation of NF-kB (nuclear factor kappa-light-chain-enhancer of activated B cells) by interacting with COMMD (copper metabolism Murr1 domain-containing) proteins. The mouse orthologous protein has been shown to bind copines, which are calcium-dependent, membrane-binding proteins that may function in calcium signaling. This human gene has been identified as a novel candidate gene for syndromic X-linked intellectual disability. [provided by RefSeq, Aug 2013]
CCDC22 Gene-Disease associations (from GenCC):
  • Ritscher-Schinzel syndrome 2
    Inheritance: XL Classification: STRONG, MODERATE, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics, ClinGen
  • Ritscher-Schinzel syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy
    Inheritance: XL Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.018668264).
BP6
Variant X-49247754-G-A is Benign according to our data. Variant chrX-49247754-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 434618.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Hemizygotes in GnomAd4 at 2 XL,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CCDC22NM_014008.5 linkc.1078G>A p.Val360Ile missense_variant Exon 9 of 17 ENST00000376227.4 NP_054727.1
CCDC22XM_005272599.5 linkc.1075G>A p.Val359Ile missense_variant Exon 9 of 17 XP_005272656.1
CCDC22XR_430506.4 linkn.1245G>A non_coding_transcript_exon_variant Exon 9 of 11

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CCDC22ENST00000376227.4 linkc.1078G>A p.Val360Ile missense_variant Exon 9 of 17 1 NM_014008.5 ENSP00000365401.3

Frequencies

GnomAD3 genomes
AF:
0.0000891
AC:
10
AN:
112283
Hom.:
0
Cov.:
24
show subpopulations
Gnomad AFR
AF:
0.0000324
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000281
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00418
Gnomad NFE
AF:
0.000132
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000613
AC:
11
AN:
179301
AF XY:
0.0000307
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000367
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000145
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000627
Gnomad OTH exome
AF:
0.000451
GnomAD4 exome
AF:
0.0000419
AC:
46
AN:
1097314
Hom.:
0
Cov.:
32
AF XY:
0.0000441
AC XY:
16
AN XY:
362824
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26397
American (AMR)
AF:
0.0000569
AC:
2
AN:
35163
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19374
East Asian (EAS)
AF:
0.0000331
AC:
1
AN:
30198
South Asian (SAS)
AF:
0.0000556
AC:
3
AN:
53942
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40273
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4126
European-Non Finnish (NFE)
AF:
0.0000451
AC:
38
AN:
841783
Other (OTH)
AF:
0.0000434
AC:
2
AN:
46058
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
3
6
8
11
14
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000890
AC:
10
AN:
112339
Hom.:
0
Cov.:
24
AF XY:
0.0000580
AC XY:
2
AN XY:
34497
show subpopulations
African (AFR)
AF:
0.0000323
AC:
1
AN:
30961
American (AMR)
AF:
0.00
AC:
0
AN:
10751
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2650
East Asian (EAS)
AF:
0.000282
AC:
1
AN:
3550
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2693
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6159
Middle Eastern (MID)
AF:
0.00459
AC:
1
AN:
218
European-Non Finnish (NFE)
AF:
0.000132
AC:
7
AN:
53139
Other (OTH)
AF:
0.00
AC:
0
AN:
1534
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.538
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000727
Hom.:
0
Bravo
AF:
0.0000529
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000297
AC:
2
ExAC
AF:
0.0000660
AC:
8

ClinVar

Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Jan 08, 2024
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

Jun 20, 2017
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:1
Feb 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

CCDC22: BP4, BS2

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.061
BayesDel_addAF
Benign
-0.71
T
BayesDel_noAF
Benign
-0.99
CADD
Benign
0.15
DANN
Benign
0.73
DEOGEN2
Benign
0.19
T
FATHMM_MKL
Benign
0.0083
N
LIST_S2
Benign
0.53
T
M_CAP
Benign
0.0023
T
MetaRNN
Benign
0.019
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.2
L
PhyloP100
0.061
PrimateAI
Benign
0.31
T
PROVEAN
Benign
-0.29
N
REVEL
Benign
0.031
Sift
Benign
0.82
T
Sift4G
Benign
0.73
T
Vest4
0.035
ClinPred
0.0094
T
GERP RS
-9.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.034
gMVP
0.038
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs145766807; hg19: chrX-49104215; API